nicorandil has been researched along with Coronary Restenosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurihara, H; Matsumoto, S; Matsuyama, T; Nakagawa, T; Nakata, A; Tamura, R; Yachiku, K; Yoshino, T | 1 |
| Andron, M; Egred, M; Morrison, WL | 1 |
| Fujiwara, H; Hirose, T; Iwama, M; Kojima, T; Matsuo, H; Minatoguchi, S; Ono, K; Segawa, T; Takahashi, H; Warita, S; Watanabe, S; Watanabe, T | 1 |
2 trial(s) available for nicorandil and Coronary Restenosis
| Article | Year |
|---|---|
Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocardial infarction.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Combined Modality Therapy; Coronary Angiography; Coronary Restenosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicorandil; Plasminogen Activators; Platelet Aggregation Inhibitors; Stents; Vasodilator Agents | 2004 |
Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil.
Topics: Aged; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Nicorandil; Prospective Studies; Treatment Outcome; Vasodilator Agents; Verapamil | 2007 |
1 other study(ies) available for nicorandil and Coronary Restenosis
| Article | Year |
|---|---|
Nicorandil may be associated with gastrointestinal ulceration.
Topics: Aged; Coronary Restenosis; Female; Humans; Intestinal Diseases; Irritable Bowel Syndrome; Nicorandil; Ulcer; Vasodilator Agents | 2006 |